IART Stock Summary and Trading Ideas (Integra Lifesciences Holdings | NASDAQ:IART)

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.

Integra Lifesciences Holdings trades on the NASDAQ stock market under the symbol IART.

As of March 5, 2025, IART stock price declined to $21.87 with 515,901 million shares trading.

IART has a beta of 2.00, meaning it tends to be more sensitive to market movements. IART has a correlation of 0.18 to the broad based SPY ETF.

IART has a market cap of $1.69 billion. This is considered a Small Cap stock.

Last quarter Integra Lifesciences Holdings reported $443 million in Revenue and $.97 earnings per share. This fell short of revenue expectation by $-3 million and exceeded earnings estimates by $.11.

In the last 3 years, IART traded as high as $68.29 and as low as $16.81.

The top ETF exchange traded funds that IART belongs to (by Net Assets): IJR, VTI, VB, IWM, VBR.

IART has underperformed the market in the last year with a price return of -39.1% while the SPY ETF gained +15.2%. IART has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -9.3% and -6.2%, respectively, while the SPY returned -3.7% and -4.6%, respectively.

IART support price is $21.31 and resistance is $22.51 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IART shares will trade within this expected range on the day.